Description |
1 online resource |
|
text txt rdacontent |
|
computer c rdamedia |
|
online resource cr rdacarrier |
Series |
Oxford oncology library |
|
Oxford oncology library.
|
Note |
Print version record. |
Summary |
Lung cancer is the leading cause of cancer mortality worldwide, and non-small cell lung cancer (NSCLC) accounts for about 85% of all cases of lung cancer. Most patients present with advanced disease and five-year survival is low at about 15%. Surgery is the main treatment for early stage disease. If patients are deemed inoperable, systemic chemotherapy is considered. For patients with locally advanced disease, multimodality therapy is administered where chemotherapy is given incombination with definitive radiation therapy or surgery in selected cases. Cytotoxic chemotherapy regimens mainly con. |
Bibliography |
Includes bibliographical references and index. |
Contents |
Abbreviations; Contributors; 1 Molecular biology of lung cancer for the clinician; 2 Staging of lung cancer; 3 Systemic therapy for early-stage NSCLC; 4 Combined modality therapy for locally advanced NSCLC; 5 Systemic therapy for advanced NSCLC, efficacy, and toxicity; 6 Systemic therapy for recurrent NSCLC, efficacy, and toxicity; 7 Palliative care in NSCLC; 8 Development of new therapeutic agents for treatment of NSCLC; Index; A; B; C; D; E; F; G; H; I; K; L; M; N; O; P; R; S; T; U; V; W; Y; Z. |
Subject |
Lungs -- Cancer -- Treatment.
|
|
Carcinoma, Non-Small-Cell Lung -- therapy |
|
Poumons -- Cancer -- Traitement.
|
|
HEALTH & FITNESS -- Diseases -- General.
|
|
MEDICAL -- Clinical Medicine.
|
|
MEDICAL -- Diseases.
|
|
MEDICAL -- Evidence-Based Medicine.
|
|
MEDICAL -- Internal Medicine.
|
|
Lungs -- Cancer -- Treatment
|
Other Form: |
Print version 9780199580484 |
ISBN |
9780191502392 (electronic bk.) |
|
0191502391 (electronic bk.) |
|
1306260442 (electronic bk.) |
|
9781306260442 (electronic bk.) |
|
9780191740411 |
|
0191740411 |
|
0199580480 |
|
9780199580484 |
Standard No. |
AU@ 000055940721 |
|
DEBBG BV042792958 |
|